Canton Strategic Holdings, Inc. (CNTN) company profile
Close on Nov 17, 2026Market cap $113.15MP/E –Yield –
About Canton Strategic
Finance Services, SIC 6199
Canton Strategic Holdings, Inc. is an enterprise focused on digital asset treasury operations and clinical-stage biotechnology development. The company conducts business through two main operational segments: digital asset treasury management and biotechnology research. Within its digital asset segment, the organization holds Canton Coin, operates as a network validator, and supports the Canton Network to foster institutional blockchain adoption and the digitization of financial markets. In its biotechnology business, it develops drug candidates targeted at inflammatory and immunologic conditions characterized by significant unmet medical need. Because its pharmaceutical pipeline remains in clinical development and its digital asset activities center on network participation and balance sheet management, the filing identifies no commercial customers.
Regarding physical presence and operational scale, the provided filing contains no disclosures concerning the number of operating facilities, employee counts, or international countries of operation. The company maintains its principal executive offices in Red Bank, New Jersey.
Summary of the business section of Canton Strategic's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Canton Strategic Holdings, Inc.
- Headquarters
- New York, NY
- Address
- 1460 Broadway 10036
- Phone
- (212) 210-6006
- Website
- cantonstrategic.com
- Employees
- 12, Dec 31, 2025
- Industry
- Finance Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Rosenberg Rich Baker Berman P.A, Somerset, New Jersey
Stock & identifiers
- Ticker
- CNTN
- Former tickers
- THAR until Mar 3, 2026; HILS until Sep 25, 2023
- Exchange
- Nasdaq
- IPO date
- Jan 13, 2022
- Shares outstanding
- 80M, Aug 13, 2026
- Public float
- $6.40M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-15 reverse, May 28, 2024; 1-for-25 reverse, Nov 21, 2023
- SEC CIK
- 1861657
- CUSIP
- 432705200
- ISIN
- US4327052001
- FIGI
- BBG012QFR2V4
- Share class FIGI
- BBG012QFR3P9
- LEI
- 52990040X8C60JYNXZ70
- EIN
- 84-2642541
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Mark Paul Wendland | Chief Executive Officer, Director | – |
| Sanam Parikh | COO, Director | 1,770 |
| Sireesh Appajosyula | CEO, Director | 66,771 |
| Vincent S. LoPriore | Executive Chairman, Director | 732,424 |
| Randy Milby | CEO, Director | 17,534 |
| Mark Christopher Toomey | President | – |
| Angela Dominy Radkowski | Chief Operating Officer | – |
| Jacob Asbury | Chief Financial Officer | – |
| Dong Kim | CFO | – |
| Sean Galvin | Director | – |
| William Thomas Wiley Jr. | Director | – |
| Jill E. Sommers | Director | – |
| Rishi Nangalia | Director | – |
| Pamela L. Carter | Director | – |
| Thomas Clay Kahler | Director | – |
| Gary S. Stetz | Director | 134,175 |
| Nancy Davis Rickel | Director | – |
| James Gordon Liddy | Director | – |
| Kelly Anderson | Director | 6,300 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Option awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Mark Wendland Chief Executive Officer (1) | $83.33K | $275.00K | – | – | $358.33K | – |
| Mark Toomey President (2) | $83.33K | $125.00K | – | – | $208.33K | – |
| Jacob Asbury Chief Financial Officer (3) | $22.50K | $7.67K | – | – | $30.17K | – |
| Randy Milby Former Chief Executive Officer (4) | $357.50K | – | $121.11K | $139.85K | $618.46K | -36% |
| Sireesh Appajosyula Former Interim Chief Financial Officer, Chief Operating Officer and Chief Executive Officer (5) | $376.26K | $2.29M | $214.32K | $5.97K | $2.88M | +311% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Jan 13, 2022
- Offer price
- $4.00
- Securities offered
- 3,750,000
- Gross proceeds
- $15.00M
- Exchange
- Nasdaq
- First trading day
- Jan 12, 2022
- First-day close
- $3.48-13.0%
- Lock-up ends (est.)
- Jul 11, 2022
“The initial public offering price of our common stock is $4.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“currently employ 12 full-time employees.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?